BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Z, Wang X, Li J, Yang H, Lin X. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer. J Cell Mol Med 2018;22:4377-86. [PMID: 29992789 DOI: 10.1111/jcmm.13732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chacon-Barahona JA, Salladay-Perez IA, Lanning NJ. Lung Adenocarcinoma Transcriptomic Analysis Predicts Adenylate Kinase Signatures Contributing to Tumor Progression and Negative Patient Prognosis. Metabolites 2021;11:859. [PMID: 34940617 DOI: 10.3390/metabo11120859] [Reference Citation Analysis]
2 Jiang Z, Wang X, Li J, Yang H, Lin X. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer. J Cell Mol Med 2018;22:4377-86. [PMID: 29992789 DOI: 10.1111/jcmm.13732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lu G, Shi W, Zhang Y. Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma. Front Genet 2021;12:721021. [PMID: 34925439 DOI: 10.3389/fgene.2021.721021] [Reference Citation Analysis]
4 Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, Yi P, Pan Q, Rao S, Han Y, Tang Y, Su M, Luo X, Yang Y, Chen X, Yang L, Zhou Y, Liao Q. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity. Oncogene 2022. [PMID: 34997215 DOI: 10.1038/s41388-021-02148-y] [Reference Citation Analysis]
5 Tang Y, Yang X, Feng K, Hu C, Li S. High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma. J Gastrointest Oncol 2021;12:174-83. [PMID: 33708434 DOI: 10.21037/jgo-20-534] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Saito Y, Takasawa A, Takasawa K, Aoyama T, Akimoto T, Ota M, Magara K, Murata M, Hirohashi Y, Hasegawa T, Sawada N, Saito T, Osanai M. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma. Cancer Sci 2020;111:3071-81. [PMID: 32530543 DOI: 10.1111/cas.14524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Sexton RE, Hallak MNA, Uddin MH, Diab M, Azmi AS. Gastric Cancer Heterogeneity and Clinical Outcomes. Technol Cancer Res Treat 2020;19:1533033820935477. [PMID: 32799763 DOI: 10.1177/1533033820935477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Moldogazieva NT, Mokhosoev IM, Terentiev AA. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK. Cancers (Basel) 2020;12:E862. [PMID: 32252351 DOI: 10.3390/cancers12040862] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
9 Zhao C, Li Y, Shao L, Wang X, Lu J, Li X, Chen L, Cui X, Sheng W, Deng X, Wu Y. Reactive oxygen species-responsive theranostic nanoparticles for enhanced hypoxic tumor photodynamic therapy via synchronous HIF-1α inhibition and ATP depletion. Mater Chem Front 2019;3:1793-9. [DOI: 10.1039/c9qm00270g] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
10 Ghanavat M, Shahrouzian M, Deris Zayeri Z, Banihashemi S, Kazemi SM, Saki N. Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci 2021;264:118603. [PMID: 33091446 DOI: 10.1016/j.lfs.2020.118603] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Carvalho TM, Cardoso HJ, Figueira MI, Vaz CV, Socorro S. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy. Eur J Med Chem 2019;171:343-63. [PMID: 30928707 DOI: 10.1016/j.ejmech.2019.03.053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
12 Cui G, Cai F, Ding Z, Gao L. HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. Hum Pathol 2019;84:133-41. [PMID: 30296520 DOI: 10.1016/j.humpath.2018.09.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
13 Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 2020;20:74-88. [PMID: 31686003 DOI: 10.1038/s41568-019-0216-7] [Cited by in Crossref: 235] [Cited by in F6Publishing: 248] [Article Influence: 78.3] [Reference Citation Analysis]